Literature DB >> 1852094

Calcium absorption in elderly subjects on high- and low-fiber diets: effect of gastric acidity.

T A Knox1, Z Kassarjian, B Dawson-Hughes, B B Golner, G E Dallal, S Arora, R M Russell.   

Abstract

In vitro studies suggest that the effect of fiber in inhibiting calcium absorption is pH dependent. In nine normal, elderly control subjects and eight elderly subjects with achlorhydria, 47Ca was ingested with three test meals: a low-fiber meal (0.5 g dietary fiber), a high-fiber meal (10.5 g), and a high-fiber meal with 120 mL of 0.1 mol HC/L. In control subjects calcium retention, measured in a whole-body counter, was 25.7 +/- 4.0% (mean +/- SD) with the low-fiber meal, 19.1 +/- 1.9% with the high-fiber meal (P less than 0.002 vs low fiber), and 18.9 +/- 3.3% with the high-fiber-plus-acid meal (P less than 0.002 vs low fiber, NS vs high fiber). Calcium absorption in achlorhydric subjects was not different from control subjects: 26.2 +/- 8.0% with low fiber, 19.6 +/- 4.1% with high fiber (P less than 0.04 vs low fiber), and 21.0 +/- 5.8% with high fiber plus acid (P less than 0.04 vs low fiber, NS vs high fiber). We conclude that, in humans, the reduction in calcium absorption with high fiber intake is unaffected by gastric pH.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1852094     DOI: 10.1093/ajcn/53.6.1480

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN: 0002-9165            Impact factor:   7.045


  9 in total

1.  Inhibiting gastric acid production does not affect intestinal calcium absorption in young, healthy individuals: a randomized, crossover, controlled clinical trial.

Authors:  Matthew J Wright; Rebecca R Sullivan; Erin Gaffney-Stomberg; Donna M Caseria; Kimberly O O'Brien; Deborah D Proctor; Christine A Simpson; Jane E Kerstetter; Karl L Insogna
Journal:  J Bone Miner Res       Date:  2010-10       Impact factor: 6.741

2.  [Disorders of calcium metabolism].

Authors:  C Kasperk; H Bartl
Journal:  Internist (Berl)       Date:  2014-11       Impact factor: 0.743

3.  Absorption of calcium from tortilla meals prepared from low-phytate maize.

Authors:  K Michael Hambidge; Nancy F Krebs; Jamie L Westcott; Lei Sian; Leland V Miller; Kevin L Peterson; Victor Raboy
Journal:  Am J Clin Nutr       Date:  2005-07       Impact factor: 7.045

4.  Proton pump inhibitors and histamine-2 receptor antagonists are associated with hip fractures among at-risk patients.

Authors:  Douglas A Corley; Ai Kubo; Wei Zhao; Charles Quesenberry
Journal:  Gastroenterology       Date:  2010-03-27       Impact factor: 22.682

5.  Postmenopausal women with osteoporosis consume high amounts of vegetables but insufficient dairy products and calcium to benefit from their virtues: the CoLaus/OsteoLaus cohort.

Authors:  A Lanyan; P Marques-Vidal; E Gonzalez-Rodriguez; D Hans; O Lamy
Journal:  Osteoporos Int       Date:  2019-12-17       Impact factor: 4.507

6.  Whole grain intake, incident hip fracture and presumed frailty in the Iowa Women's Health Study.

Authors:  David R Jacobs; Christina Hohe; Jaakko Mursu; Kim Robien; Aaron R Folsom
Journal:  Br J Nutr       Date:  2010-06-23       Impact factor: 3.718

Review 7.  Association of long-term proton pump inhibitor therapy with bone fractures and effects on absorption of calcium, vitamin B12, iron, and magnesium.

Authors:  Tetsuhide Ito; Robert T Jensen
Journal:  Curr Gastroenterol Rep       Date:  2010-12

8.  Use of proton pump inhibitors and risk of hip/femur fracture: a population-based case-control study.

Authors:  S Pouwels; A Lalmohamed; P Souverein; C Cooper; B J Veldt; H G Leufkens; A de Boer; T van Staa; F de Vries
Journal:  Osteoporos Int       Date:  2010-06-29       Impact factor: 4.507

9.  Relevance of vitamin D deficiency in patients with chronic autoimmune atrophic gastritis: a prospective study.

Authors:  Sara Massironi; Federica Cavalcoli; Alessandra Zilli; Alessandro Del Gobbo; Clorinda Ciafardini; Susanna Bernasconi; Irene Felicetta; Dario Conte; Maddalena Peracchi
Journal:  BMC Gastroenterol       Date:  2018-11-08       Impact factor: 3.067

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.